Robot Aug

China's backflipping humanoid robotics firm Unitree soars on IPO: How else to position for the robotics revolution

ETFs 7 minutes to read
Note: This is marketing material. This article is not investment advice, capital is at risk.

The robots are coming; Shares of Chinese humanoid robotics firm Unitree soared on debut as investors scrambled for a piece of the nascent industry that has few major listed companies.

Shares in the backflipping robot maker surged as much as 629% on their Shanghai debut, closing around 460% above the IPO price. The company raised about $900 million, but retail demand exceeded the shares available by several thousand times

Trading on Shanghai’s STAR Market it's not an easy stock to access from the UK. However, there are other ways investors can position for the humanoid robotics revolution.

Humanoids are a rare breed

In terms of humanoid robots, there are slim pickings for investors globally. That probably explains the huge excitement around Unitree – quite apart from its backflipping humanoid robots being at the forefront of the tech, there is not a lot else.

Tesla is developing its Optimus humanoid but has so far preferred to show this with a guy dressed in a suit, while Hyundai-owned Boston Dynamics remains private. China has Unitree, but also UBTech and a rapidly expanding collection of privately owned manufacturers. Several other Chinese humanoid robotic firms are preparing to go public, including Deep Robotics and Leju Robotics.

Among US-listed stocks that UK investors can access easily, companies like Serve Robotics and Richtech Robotics on a broader range of autonomous solutions rather than pureplay humanoid robots. WeRide, another in the robotics space, develops autonomous driving tech that its CEO compared to Tesla's FSD.

Robotics remains a frontier play with uncertain outcomes for companies at the coalface, particularly in the field of humanoid robots. However, there is a broader thematic play in terms of autonomy, AI and automation.

The picks-and-shovels approach

Investors can look around the companies supplying the industry. This approach is less dependent on any one finished robot succeeding. This is the broadest way to play the theme.

For example,

  • Nvidia or Arm for computing

  • Keyence for sensors and machine vision

  • Yaskawa for motors and controls

  • Harmonic Drive or Nabtesco for precision components

  • Siemens or Rockwell for industrial software and automation

Computing: Obviously robots need compute and Nvidia is the most obvious beneficiary: its chips are used for training AI models, while its Jetson computing platform and robotics software help robots process information and make decisions in the physical world. Other semiconductor companies supply the microcontrollers, connectivity, analogue chips and power-management systems required inside robots. These include Arm, Qualcomm, Texas Instruments, Infineon and STMicroelectronics.

Components: Robots need precision parts capable of translating software commands into movement. This creates opportunities for manufacturers of servo motors, drives, reducers, sensors and machine-vision equipment. Japan is particularly strong here. Keyence supplies sensors and machine-vision systems; Harmonic Drive and Nabtesco produce precision gears and reducers; SMC makes pneumatic equipment; while Yaskawa manufactures servo motors, controls and complete industrial robots.

Automation: Fanuc and Yaskawa of Japan, Siemens of Germany and Rockwell Automation of the US provide investors with exposure to the established market of industrial robots. In healthcare, Intuitive Surgical already has a successful robotics business through its da Vinci surgical systems. I'm not even going to mention Ocado.

The ETF route

For many investors, an ETF may be a more sensible way to approach such an uncertain and fast-changing industry. It reduces the risk of choosing the wrong robot manufacturer while providing exposure across equipment makers, components, semiconductors and software.

UK retail investors should normally look for UCITS-compliant funds rather than US-listed ETFs.

ETF

Ticker

Approach

Best suited to

iShares Automation & Robotics UCITS ETF

RBOT

Broad global portfolio of automation and robotics-related companies

A diversified core robotics holding

L&G ROBO Global Robotics and Automation UCITS ETF

ROBO

Specialist robotics, automation and enabling technology exposure

A more targeted thematic allocation

Global X Robotics & Artificial Intelligence UCITS ETF

BOTZ

Industrial automation, robotics, AI and autonomous systems

Investors wanting larger established automation companies

WisdomTree Artificial Intelligence UCITS ETF

WTAI

Wider AI value chain, including robotics and enabling technologies

Broader AI exposure rather than a pure robotics bet

Amundi MSCI Robotics & AI ESG Screened UCITS ETF

GOAI

Robotics and AI companies with ESG screens

Investors wanting broad thematic diversification

 

 

 

 

 

 

 

 

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

This content is marketing material. 

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Market Ltd. (SCML) provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice or a recommendation.

SCML content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

SCML partners with companies that provide compensation for promotional activities conducted on its platform. Some partners also pay retrocessions contingent on clients investing in products from those partners. 

While SCML receives compensation from these partnerships, all educational and research content remains focused on providing information to clients.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. SCML does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992